Завершено
Фаза II
Россия
gemcitabine hydrochloride; Serine Proteinase Inhibitor WX-671; Serine Proteinase Inhibitor WX-671 · Heidelberg Pharma AG
A Randomized, Open Label, Phase II Proof of Concept Study of WX-671 in Combination With Gemcitabine vs.Gemcitabine Alone in Patients With Locally Advanced, Non Resectable Pancreatic Cancer in Order to Evaluate the Anti-Tumor Activity of the Combination Therapy